174 related articles for article (PubMed ID: 33065283)
1. The ubiquitin-proteasome system and its crosstalk with mitochondria as therapeutic targets in medicine.
Kodroń A; Mussulini BH; Pilecka I; Chacińska A
Pharmacol Res; 2021 Jan; 163():105248. PubMed ID: 33065283
[TBL] [Abstract][Full Text] [Related]
2. K(ATP) channel block prevents proteasome inhibitor-induced apoptosis in differentiated PC12 cells.
Nam YJ; Lee DH; Lee MS; Lee CS
Eur J Pharmacol; 2015 Oct; 764():582-591. PubMed ID: 26142827
[TBL] [Abstract][Full Text] [Related]
3. Control of mitochondrial biogenesis and function by the ubiquitin-proteasome system.
Bragoszewski P; Turek M; Chacinska A
Open Biol; 2017 Apr; 7(4):. PubMed ID: 28446709
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proteasome reveals basal mitochondrial ubiquitination.
Sulkshane P; Duek I; Ram J; Thakur A; Reis N; Ziv T; Glickman MH
J Proteomics; 2020 Oct; 229():103949. PubMed ID: 32882436
[TBL] [Abstract][Full Text] [Related]
5. The regulation of mitochondrial homeostasis by the ubiquitin proteasome system.
Alsayyah C; Ozturk O; Cavellini L; Belgareh-Touzé N; Cohen MM
Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148302. PubMed ID: 32861697
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition.
Maharjan S; Oku M; Tsuda M; Hoseki J; Sakai Y
Sci Rep; 2014 Jul; 4():5896. PubMed ID: 25077633
[TBL] [Abstract][Full Text] [Related]
7. On the linkage between the ubiquitin-proteasome system and the mitochondria.
Lehmann G; Udasin RG; Ciechanover A
Biochem Biophys Res Commun; 2016 Apr; 473(1):80-86. PubMed ID: 26996128
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates proteasome inhibition-induced apoptosis by suppressing the activation of the mitochondrial pathway and the caspase-8- and Bid-dependent pathways.
Jung EB; Lee CS
Eur J Pharmacol; 2014 May; 730():116-24. PubMed ID: 24631255
[TBL] [Abstract][Full Text] [Related]
9. The role of the immunoproteasome in cardiovascular disease.
Nie Y; Ma Z; Zhang B; Sun M; Zhang D; Li HH; Song X
Pharmacol Res; 2024 Jun; 204():107215. PubMed ID: 38744399
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-proteasome system and mitochondria - reciprocity.
Livnat-Levanon N; Glickman MH
Biochim Biophys Acta; 2011 Feb; 1809(2):80-7. PubMed ID: 20674813
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
12. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial and Ubiquitin Proteasome System Dysfunction in Ageing and Disease: Two Sides of the Same Coin?
Ross JM; Olson L; Coppotelli G
Int J Mol Sci; 2015 Aug; 16(8):19458-76. PubMed ID: 26287188
[TBL] [Abstract][Full Text] [Related]
14. Melatonin, bone regulation and the ubiquitin-proteasome connection: A review.
Vriend J; Reiter RJ
Life Sci; 2016 Jan; 145():152-60. PubMed ID: 26706287
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome system.
Segref A; Kevei É; Pokrzywa W; Schmeisser K; Mansfeld J; Livnat-Levanon N; Ensenauer R; Glickman MH; Ristow M; Hoppe T
Cell Metab; 2014 Apr; 19(4):642-52. PubMed ID: 24703696
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved shifts in ubiquitin-proteasome system (UPS) activity drive mitochondrial remodeling during quiescence.
Yue S; Wang L; DeMartino GN; Zhao F; Liu Y; Sieber MH
Nat Commun; 2022 Aug; 13(1):4462. PubMed ID: 35915093
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial quality control by the ubiquitin-proteasome system.
Taylor EB; Rutter J
Biochem Soc Trans; 2011 Oct; 39(5):1509-13. PubMed ID: 21936843
[TBL] [Abstract][Full Text] [Related]
18. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
[TBL] [Abstract][Full Text] [Related]
19. Associations between autophagy, the ubiquitin-proteasome system and endoplasmic reticulum stress in hypoxia-deoxygenation or ischemia-reperfusion.
Fan T; Huang Z; Chen L; Wang W; Zhang B; Xu Y; Pan S; Mao Z; Hu H; Geng Q
Eur J Pharmacol; 2016 Nov; 791():157-167. PubMed ID: 27568838
[TBL] [Abstract][Full Text] [Related]
20. Decoding the rosetta stone of mitonuclear communication.
English J; Son JM; Cardamone MD; Lee C; Perissi V
Pharmacol Res; 2020 Nov; 161():105161. PubMed ID: 32846213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
